Has Siddharth Singh received payments from drug or device companies?

Yes. Drug and device makers reported $6,568 in general payments to Siddharth Singh across 43 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Siddharth Singh did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Siddharth Singh come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Siddharth Singh

Cardiovascular Disease · West Hollywood, CANPI 1316137136

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (40.6%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Canon Medical Systems USA, Inc. at 38.1% of the total. Reporting peaked in 2023 at $3,066 and has fallen 58.6% since, to $1,269 in 2025.

$6,568in general payments, 2019–2025

Across 43 payments — averaging $152.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Canon Medical Systems USA, Inc.$3K
Abbott$2K
Edwards Lifesciences$1K
Inari Medical, Inc.$207
Actelion Pharmaceuticals US, Inc.$158
E.r. Squibb & Sons, L.L.C.$122
plus $122 from 3 others

$27,197in research payments, 2019–2025

Across 14 payments — averaging $1942.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Edwards Lifesciences$26K
Boston Scientific$1K

What the payments were for

Consulting fees$2,50038%
Travel & lodging$2,66741%
Food & beverage$1,40121%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Canon Medical Systems USA, Inc.	1	$2,500
Abbott	16	$2,097
Edwards Lifesciences	19	$1,362
Inari Medical, Inc.	1	$207
Actelion Pharmaceuticals US, Inc.	2	$158
E.r. Squibb & Sons, L.L.C.	1	$122
Abiomed	1	$81
Amgen	1	$22
Bayer	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,568 in reported general payments places this provider in the 70th percentile of 2,184 cardiovascular disease providers in California.

See all cardiovascular disease providers in California →

Medicare billing

Part B allowed, 2024

$191,079

Medicare patients

1,612

Services billed

2,973

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Repatha SureclickEvolocumab	44	$28,747
FarxigaDapagliflozin Propanediol	26	$22,369
EliquisApixaban	29	$19,536
XareltoRivaroxaban	16	$13,387
JardianceEmpagliflozin	13	$6,243
VascepaIcosapent Ethyl	13	$2,170
Ezetimibe	53	$1,540
Rosuvastatin Calcium	53	$1,278
Nitroglycerin	32	$913
Metoprolol Succinate	40	$544
Ranolazine ErRanolazine	16	$347
Isosorbide Mononitrate ErIsosorbide Mononitrate	23	$234
Amlodipine Besylate	50	$208
Atorvastatin Calcium	34	$170
ClopidogrelClopidogrel Bisulfate	27	$164

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in West Hollywood

Florian RaderWest Hollywood$339K
Ted LoveHillsborough$102.8M
Paul KurthSanta Barbara$6.1M
Jason RogersSacramento$4.4M
Matthew BudoffTorrance$3.6M
Eric Topolla Jolla$2.2M
Cathleen Bairey-MerzLos Angeles$1.2M
Gagan SinghSacramento$1.2M
Pam Taubla Jolla$1.2M
Wilber SuStanford$1.1M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →